Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Cancer

Fig. 1

From: Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection

Fig. 1

Expression of EpCAM mRNA+ CTC and Treg/CD4+ in HCC recurrence vs no recurrence group. a, Based on 2−ΔΔC q algorithm transformation, the relative EpCAM mRNA expression of CTC in HCC patients with or without tumor recurrence after resection. EpCAM mRNA+ CTC showed significantly higher in recurrence patients (p = 0.001); b, The high ratio of Treg/CD4+ was observed d in recurrence group (p = 0.0197)

Back to article page